1. Home
  2. VEEE vs CNSP Comparison

VEEE vs CNSP Comparison

Compare VEEE & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VEEE
  • CNSP
  • Stock Information
  • Founded
  • VEEE 1994
  • CNSP 2017
  • Country
  • VEEE United States
  • CNSP United States
  • Employees
  • VEEE N/A
  • CNSP N/A
  • Industry
  • VEEE Marine Transportation
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • VEEE Industrials
  • CNSP Health Care
  • Exchange
  • VEEE Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • VEEE 6.4M
  • CNSP 5.6M
  • IPO Year
  • VEEE 2021
  • CNSP 2019
  • Fundamental
  • Price
  • VEEE $2.46
  • CNSP $1.04
  • Analyst Decision
  • VEEE
  • CNSP Hold
  • Analyst Count
  • VEEE 0
  • CNSP 1
  • Target Price
  • VEEE N/A
  • CNSP N/A
  • AVG Volume (30 Days)
  • VEEE 127.0K
  • CNSP 224.0K
  • Earning Date
  • VEEE 05-14-2025
  • CNSP 05-14-2025
  • Dividend Yield
  • VEEE N/A
  • CNSP N/A
  • EPS Growth
  • VEEE N/A
  • CNSP N/A
  • EPS
  • VEEE N/A
  • CNSP N/A
  • Revenue
  • VEEE $14,388,517.00
  • CNSP N/A
  • Revenue This Year
  • VEEE N/A
  • CNSP N/A
  • Revenue Next Year
  • VEEE N/A
  • CNSP N/A
  • P/E Ratio
  • VEEE N/A
  • CNSP N/A
  • Revenue Growth
  • VEEE N/A
  • CNSP N/A
  • 52 Week Low
  • VEEE $2.13
  • CNSP $0.77
  • 52 Week High
  • VEEE $9.70
  • CNSP $800.00
  • Technical
  • Relative Strength Index (RSI)
  • VEEE 41.40
  • CNSP 36.68
  • Support Level
  • VEEE $2.05
  • CNSP $0.83
  • Resistance Level
  • VEEE $2.84
  • CNSP $1.37
  • Average True Range (ATR)
  • VEEE 0.53
  • CNSP 0.15
  • MACD
  • VEEE -0.03
  • CNSP 0.07
  • Stochastic Oscillator
  • VEEE 18.22
  • CNSP 44.82

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: